Zhejiang Huaye Plastics Machinery
301616
Alnera Aluminium
301613
Glory View Technology
301396
4
Guangzhou Sie Consulting
300687
5
Tibet Duo Rui Pharmaceutical
301075
(FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||
Goods sale service render cash | 18.47%29.57B | 17.50%21.38B | 16.07%13.55B | 10.29%6.01B | -19.63%24.96B | -20.96%18.2B | -23.20%11.68B | -21.15%5.45B | 45.29%31.05B | 38.39%23.02B |
Refunds of taxes and levies | 9.62%983.3M | -3.42%773.97M | -11.42%557.93M | 4.28%288.13M | -52.37%897.04M | -38.32%801.38M | -22.19%629.87M | -33.06%276.29M | 56.46%1.88B | 47.79%1.3B |
Cash received relating to other operating activities | 10.63%559.32M | 38.71%709.55M | 29.35%514.77M | -64.94%146.83M | -6.82%505.59M | -16.27%511.53M | 5.80%397.97M | 258.71%418.82M | 36.73%542.6M | -3.29%610.96M |
Cash inflows from operating activities | 18.02%31.11B | 17.20%22.86B | 15.12%14.62B | 4.89%6.44B | -21.27%26.36B | -21.75%19.51B | -22.49%12.7B | -17.42%6.14B | 45.73%33.48B | 37.39%24.93B |
Goods services cash paid | 8.73%18.55B | 11.18%14.67B | 3.36%9.62B | -8.03%4.36B | -20.15%17.06B | -23.52%13.2B | -17.16%9.31B | -4.08%4.75B | 44.67%21.37B | 40.89%17.26B |
Staff behalf paid | 1.33%1.91B | -4.53%1.35B | -7.02%869.74M | -10.28%496.95M | 0.08%1.88B | 1.27%1.42B | 8.65%935.36M | 14.50%553.89M | 11.49%1.88B | 11.83%1.4B |
All taxes paid | -19.19%1.23B | -24.91%946.49M | -11.23%648.91M | -28.27%252.57M | -14.68%1.52B | -3.66%1.26B | -25.11%731.02M | -21.98%352.09M | 21.50%1.78B | 15.22%1.31B |
Cash paid relating to other operating activities | 8.46%1.8B | 141.50%1.18B | 132.80%826.19M | -5.04%173.79M | -6.47%1.66B | -8.16%489.51M | -14.51%354.9M | -35.91%183.02M | 181.56%1.78B | -28.35%533M |
Cash outflows from operating activities | 6.16%23.49B | 10.94%18.16B | 5.62%11.97B | -9.37%5.29B | -17.46%22.13B | -20.16%16.37B | -16.01%11.33B | -5.41%5.83B | 44.47%26.81B | 33.28%20.5B |
Net cash flows from operating activities | 80.05%7.62B | 49.78%4.71B | 93.54%2.66B | 273.61%1.16B | -36.56%4.23B | -29.09%3.14B | -52.64%1.37B | -75.66%309.76M | 51.01%6.67B | 60.23%4.43B |
Investing cash flow | ||||||||||
Cash received from disposal of investments | --20M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 710.00%16.2M | 3,090.00%63.8M |
Cash received from returns on investments | -99.17%2.1M | ---- | ---- | ---- | 429.45%252.02M | --252M | --252M | ---- | --47.6M | ---- |
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -95.84%102.51M | -98.73%29.62M | -99.20%4.39M | ---- | 13,897.07%2.46B | 189,472.55%2.33B | 53,792.32%550.03M | -13.16%775.2K | 3.05%17.61M | 29.15%1.23M |
Net cash received from disposal of subsidiaries and other business units | -48.49%560.09M | 89.61%560.09M | --296.5M | --198M | --1.09B | --295.4M | ---- | ---- | ---- | ---- |
Cash received relating to other investing activities | 32,936.31%704.75K | ---- | ---- | ---- | -99.99%2.13K | 163,490.73%35M | ---- | ---- | 479,956.21%19.68M | -99.99%21.4K |
Cash inflows from investing activities | -81.98%685.41M | -79.73%589.72M | -62.48%300.89M | 25,441.82%198M | 3,663.02%3.8B | 4,372.61%2.91B | 35,672.88%802.03M | -96.29%775.2K | 429.53%101.08M | -83.79%65.05M |
Cash paid to acquire fixed assets intangible assets and other long-term assets | 26.89%2.79B | 0.44%1.47B | 3.07%765.4M | 125.57%331.77M | 38.10%2.2B | 65.88%1.46B | 6.72%742.59M | -73.99%147.08M | 33.19%1.59B | 11.59%880.21M |
Cash paid to acquire investments | 184.15%836.54M | 179.73%816.54M | 32.42%386.53M | ---- | 29,340.00%294.4M | 29,090.00%291.9M | 29,090.00%291.9M | ---- | -96.21%1M | -79.59%1M |
Cash paid relating to other investing activities | --779.53K | ---- | ---- | ---- | ---- | --35M | --35M | ---- | ---- | ---- |
Cash outflows from investing activities | 45.46%3.63B | 27.76%2.28B | 7.71%1.15B | 125.57%331.77M | 56.46%2.5B | 102.79%1.79B | 53.48%1.07B | -75.38%147.08M | 30.40%1.6B | -37.45%881.21M |
Net cash flows from investing activities | -325.53%-2.95B | -250.87%-1.69B | -218.19%-851.03M | 8.57%-133.77M | 187.41%1.31B | 237.52%1.12B | 61.49%-267.46M | 74.62%-146.31M | -24.08%-1.49B | 19.00%-816.16M |
Financing cash flow | ||||||||||
Cash received from capital contributions | -99.85%361.31K | ---- | ---- | ---- | --240.07M | --224.45M | --43.06M | ---- | ---- | ---- |
-Including: Cash received from capital contributions by minority shareholders of subsidiaries | -99.85%361.31K | ---- | ---- | ---- | --240.07M | --224.45M | --43.06M | ---- | ---- | ---- |
Cash from borrowing | -13.36%10.68B | -21.31%8.19B | -14.74%4.63B | 23.75%3.54B | 22.96%12.33B | 35.15%10.41B | -0.54%5.43B | -7.47%2.86B | 23.99%10.02B | 13.15%7.7B |
Cash received relating to other financing activities | 82.44%7.83B | 126.81%7.12B | 141.55%3.41B | 190.45%3.2B | 39.33%4.29B | 48.52%3.14B | 0.24%1.41B | -4.15%1.1B | 243.50%3.08B | 369.57%2.11B |
Cash inflows from financing activities | 9.79%18.51B | 11.17%15.31B | 16.75%8.04B | 70.10%6.73B | 28.64%16.86B | 40.32%13.77B | 0.25%6.89B | -6.57%3.96B | 35.62%13.1B | 23.65%9.81B |
Borrowing repayment | 3.38%12.63B | 25.71%10.7B | 27.14%5.7B | 78.25%4.44B | 11.92%12.21B | 7.71%8.51B | -9.59%4.49B | -17.23%2.49B | 111.39%10.91B | 59.32%7.9B |
Dividend interest payment | 233.11%2.8B | 141.24%1.85B | 185.22%1.78B | 30.99%133.72M | -19.70%840.94M | -23.02%768.47M | -32.15%624.19M | 22.92%102.08M | 13.32%1.05B | 22.49%998.28M |
-Including:Cash payments for dividends or profit to minority shareholders | 288.47%287.09M | 191.37%220.05M | --196.37M | ---- | --73.9M | --75.52M | ---- | ---- | ---- | ---- |
Cash payments relating to other financing activities | 19.44%7.63B | 0.16%6.1B | 48.31%3.89B | 109.19%3.01B | 123.02%6.39B | 191.81%6.09B | 59.29%2.62B | 66.35%1.44B | -14.68%2.87B | -17.37%2.09B |
Cash outflows from financing activities | 18.59%23.06B | 21.37%18.66B | 47.08%11.37B | 88.09%7.59B | 31.16%19.44B | 39.89%15.37B | 2.72%7.73B | 1.86%4.03B | 56.96%14.82B | 32.37%10.99B |
Net cash flows from financing activities | -75.95%-4.55B | -108.95%-3.35B | -293.64%-3.33B | -1,003.49%-858.06M | -50.36%-2.59B | -36.29%-1.6B | -28.55%-847.15M | -128.35%-77.76M | -890.63%-1.72B | -221.38%-1.18B |
Net cash flow | ||||||||||
Exchange rate change effecting cash and cash equivalents | -85.88%14.07M | -104.15%-8.34M | -115.97%-42.82M | -119.82%-10.37M | -16.52%99.66M | -32.08%200.97M | 173.53%268.11M | 345.54%52.32M | 176.97%119.39M | 6,780.91%295.89M |
Adjustment items effecting cash and cash equivalents | ---- | ---- | ---- | ---- | ---- | ---- | --0.01 | ---- | ---- | ---- |
Net increase in cash and cash equivalents | -95.70%131.2M | -111.92%-341.5M | -398.87%-1.57B | 12.39%155.12M | -14.65%3.05B | 4.63%2.86B | -67.97%526.05M | -85.46%138.02M | 9.12%3.57B | 97.05%2.74B |
Add:Begin period cash and cash equivalents | 16.71%21.29B | 16.71%21.29B | 16.71%21.29B | 36.32%21.29B | 24.35%18.24B | 24.35%18.24B | 24.35%18.24B | 6.47%15.62B | 28.73%14.67B | 28.73%14.67B |
End period cash equivalent | 0.62%21.42B | -0.74%20.95B | 5.07%19.72B | 36.11%21.45B | 16.71%21.29B | 21.25%21.11B | 15.05%18.77B | 0.88%15.76B | 24.35%18.24B | 36.15%17.41B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
Auditor | Hexin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Hexin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Hexin Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.